$NDRA News
Last published 2mo ago
- 2mo agoNDRAASPIENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business UpdateBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial
- 3mo agoASPINDRAASP Isotopes Issues Letter to ShareholdersGlobeNewswireDALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes", "ASPI" or the "Company"), an advanced materials company focused on developing technologies and
- 3mo agoASPINDRAJoin the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium CompanyACCESS NewswireNoble Africa was created to unlock the value of Renergen's Virginia Gas Project through a public company focused on helium and LNGLearn why the Virginia Gas Project is positioned to become one of the world's
- 4mo agoNDRAASPIASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement FinancingBusiness WireCombination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen’s Virginia Gas Project Listing expected to provide investors with direct exposure to one of the few publicly
- 4mo agoASPINDRAASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement FinancingGlobeNewswireCombination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen’s Virginia Gas Project Listing expected to provide investors with direct exposure to one of the few publicly
- 5mo agoNDRAENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business UpdateBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for
- 6mo agoNDRAENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and ReproducibilityBusiness WireResults confirm accurate and consistent liver steatosis assessment performance across operators, geographies and patient populations, supporting planned regulatory pathway ENDRA Life Sciences Inc. (NASDAQ:NDRA)
- 7mo agoNDRAENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for
- 7mo agoNDRAENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder ValueBusiness WireBoard to evaluate a range of alternatives while continuing to support core business priorities ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for early
- 8mo agoNDRAENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient CareBusiness WireAchieved Intraclass Correlation Coefficient (ICC) of 0.89 with standard error of measurement (SEM) of 3.3% using independent operators ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in
- 11mo agoNDRAENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial UseBusiness WireFeasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ENDRA Life Sciences Inc. (NASDAQ:NDRA)
- 11mo agoNDRAENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH BiomarkerBusiness WireTAEUS Liver demonstrates strong agreement with the industry's imaging gold standard, MRI‑PDFF, across the full spectrum of steatotic liver disease and patient BMI ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the
- 11mo agoNDRAENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial ResultsBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease ("MASLD") and
- 12mo agoNDRAENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCABusiness WireENDRA is converting static treasury assets into a dynamic rewards engine to support medical innovation ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in imaging technologies for the early
- 1y agoNDRAENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token HoldingsBusiness WireCompany Officially Launches Digital Asset Treasury Strategy Focused on the Highest Conviction Holdings of Arca Investment Management to Enhance Long-Term Shareholder Value ENDRA Life Sciences Inc. (NASDAQ:NDRA)
- 1y agoNDRAENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager ArcaBusiness WireCompany Also Intends to Appoint Jeff Dorman to Digital Asset Advisory Board ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer in imaging technologies for the early detection and monitoring
- 1y agoNDRAENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial ResultsBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three and six months ended June 30,
- 1y agoNDRAENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold StandardBusiness WireRefinements to probe configuration and proprietary algorithms are expected to drive substantial improvements in MRI-PDFF correlation ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer in imaging technologies for the
- 1y agoNDRAENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial ResultsBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three months ended March 31,
- 1y agoNDRAENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 TherapiesBusiness WireEnhanced strategic focus for TAEUS addresses a large, unmet global need for a cost-effective tool for monitoring liver health at the point of patient care ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of
- 1y agoNDRAENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business UpdateBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the fourth quarter and full-year ended December 31, 2024, and provided a
- 1y agoNDRAENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price RequirementBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it has regained compliance with the minimum bid price requirement set forth by The Nasdaq
- 1y agoNDRAENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business UpdateBusiness WireCompany accelerated enrollment in global multisite pilot study and significantly reduced operating expenses while refocusing resources to clinical and regulatory deliverables ENDRA Life Sciences Inc. (NASDAQ:NDRA), a
- 1y agoNDRAStudy Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024Business WireENDRA Life Sciences Inc. (NASDAQ:NDRA), an innovator of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced the acceptance of a poster titled "Noninvasive assessment of steatotic liver disease in
- 2y agoNDRAENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European PatentBusiness WireGlobal Intellectual Property Portfolio Now Includes 82 Issued Patents ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office
- 2y agoNDRAENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in GermanyBusiness WireScans first patient in post-CE mark clinical study with Munich's center of excellence in Europe's largest healthcare market ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound
- 2y agoNDRAENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing RequirementsBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that on August 27, 2024, the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") that
- 2y agoNDRAENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNDRAENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business UpdateBusiness WireConference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), reports financial results for the three and six months
- 2y agoNDRAENDRA Life Sciences Announces Reverse Stock SplitBusiness WireShares Expected to Begin Trading on Split-Adjusted Basis on August 20, 2024 ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it
- 2y agoNDRAENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024Business WireENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that it will host a conference call and webcast beginning at 4:30 p.m. Eastern time on
- 2y agoNDRAENDRA Life Sciences Announces Leadership ChangesBusiness WireBoard Member Alexander Tokman appointed as acting CEO bringing 24+ years of global commercial leadership experience Two additional industry veterans join in key roles including regulatory and clinical affairs and
- 2y agoNDRAENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14Business WireENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three and six months ended June 30,
- 2y agoNDRAENDRA Life Sciences Announces Pricing of $8.0 Million Public OfferingBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or the "Company"), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced a public offering with gross proceeds to the Company
- 2y agoNDRAENDRA Provides Update Following In-person Meeting with FDABusiness WireIncreases clarity for ENDRA on regulatory path forward for TAEUS ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced that it has completed what it
- 2y agoNDRAENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNDRAENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business UpdateBusiness WireConference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months
- 2y agoNDRAENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024Business WireENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months ended March 31, 2024 on
- 2y agoNDRAENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsBusiness WireENDRA's IP Portfolio Reaches Milestone of 80 Issued Patents ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of five new patents, including
- 2y agoNDRAENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoNDRAENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateBusiness WireConference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and
- 2y agoNDRAENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024Business WireENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and year ended December
- 2y agoNDRAENDRA Life Sciences Installs First TAEUS System in the UKBusiness WireKing's College Hospital in London Leads UK Introduction of ENDRA Liver System ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it has installed
- 2y agoNDRANew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS SystemBusiness WireCode Complements Important Advancements by the Pharmaceutical Industry and Revised Medical Association Guidelines ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®),
- 2y agoNDRAENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and EuropeBusiness WireGlobal Intellectual Property Portfolio Expands to 74 Issued Patents ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new patents,
- 2y agoNDRAENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System TechnologyBusiness WireIntellectual Property Portfolio Now Stands at 71 Globally Issued Patents ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent
- 2y agoNDRAENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor ConferenceBusiness WireENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will be participating in The Benchmark Company's 12th Annual Discovery One-on-One
- 2y agoNDRAENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateBusiness WireConference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three and nine
- 3y agoNDRAENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New PatentsBusiness WireGlobal intellectual property portfolio increases to 70 issued patents ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of three new
- 3y agoNDRAENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023Business WireENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three and nine months ended